Sunshine Biopharma Inc.

SBFMNASDAQ • USD
2.60 USD
↘ 0.10 (3.70%)AT CLOSE (03:59 PM EST)
2.63
↗ 0.02 (0.96%)
POST MARKET (AS OF 07:53 PM EST)
Post Market
AS OF 07:53 PM EST
2.63
↗ 0.02 (0.96%)
🔴Market: CLOSED

Sunshine Biopharma Inc. (SBFM) trades at $2.61 per share. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$2.61
High?$2.68
Low?$2.55
Prev. Close?$2.70
Volume?37.1K
Avg. Volume?11.0M
VWAP?$2.62
Rel. Volume?0.00x
Bid / Ask
Bid?$2.55 × 200
Ask?$2.88 × 100
Spread?$0.33
Midpoint?$2.72
Valuation & Ratios
Market Cap?2.2M
Shares Out?823.8K
Float?14.2M
Float %?93.6%
P/E Ratio?N/A
P/B Ratio?0.08
EPS?-$7.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Employees
50
Market Cap
2.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2007-08-09
Address
333 LAS OLAS WAY
FORT LAUDERDALE, FL 33301
Phone: 954-330-0684
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
77
Short Sent.?
100
Piotroski F-Score?2/9Weak
Altman Z-Score?-1.63Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.24%Low
Short Interest?176.3K
Days to Cover?1.0
Free Float14.2M
Avg Daily Volume170.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?6.47Strong
Quick Ratio?4.03Strong
Cash Ratio?3.05Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.08CHEAP▾
P/S?
Peers
100
S&P
97
0.06CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
2.6CHEAP▾
EV/Sales?
S&P
97
-0.35CHEAP▾
Returns & Efficiency
ROE?
S&P
7
-21.6%WEAK▾
ROA?
S&P
3
-18.2%WEAK▾
Cash Flow & Enterprise
FCF?$-6035884
Enterprise Value?$-12394430
Fundamentals ratios updated end of day